Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod to Treat Ulcerative Colitis Pharmaceutical Investing
Knight Therapeutics Enters into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree® in Canada Pharmaceutical Investing
DUOBRII Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec's Public Drug Plan Pharmaceutical Investing
Ocumetics Announces December 20, 2023 Webinar regarding Successful Completion of Animal Study Geography
Medtronic creates history with FDA approval of its novel PulseSelect Pulsed Field Ablation System to treat atrial fibrillation Medical Device Investing
